Amerigen Pharmaceuticals Limited announced that its Abbreviated New Drug Application (ANDA) for cyclophosphamide capsules 25mg and 50mg has received final approval from the U.S. Food and Drug Administration. Amerigen believes that its ANDA is the first to be approved as a generic equivalent to West-Ward Pharmaceuticals’ corresponding U.S. reference listed drug. Amerigen’s generic cyclophosphamide capsules…